Actavis plc has reached a definitive agreement to acquire Auden Mckenzie for approximately £306 million in cash, plus a two-year royalty on one of Auden Mckenzie’s products. The acquisition will make Actavis the largest supplier of generics in the UK, and following the close of the acquisition of Allergan, expected later this year, Actavis will be among the largest suppliers of pharmaceuticals in the UK. Actavis currently markets more than 650 generic products in the UK, and has approxima...